Serious Adverse Events Among Older Patients in the ALTTO Trial Comparing Anti-HER2 w/ Lapatinib & Trastuzumab, Their sequence or Combination in the Adjuvant Treatment of HER2+ Early Breast Cancer

20 views
December 27, 2019
0 Comments
Login to view comments. Click here to Login